Brown Fat Activation, Metabolism, and Anti-Inflammatory Effects

How the West African spice Aframomum melegueta activates brown adipose tissue to boost calorie burning, reduce visceral fat, and calm inflammation through its active compound 6-paradol

Grains of paradise (Aframomum melegueta) is a peppery West African spice that has been used in cooking and traditional medicine for centuries. What makes it stand out scientifically is its ability to activate brown adipose tissue — a specialized fat that burns calories to generate heat — helping to raise energy expenditure and reduce visceral fat around the abdomen [1][2]. It also carries meaningful anti-inflammatory properties through its main active compound, 6-paradol, which inhibits the inflammatory enzyme COX-2 [3]. Unlike stimulants, it works through the nervous system's thermogenic pathways rather than raising heart rate or blood pressure.

How Grains of Paradise Works

Grains of paradise belongs to the ginger family (Zingiberaceae) and contains a family of pungent compounds called vanilloids — primarily 6-paradol, 6-gingerol, and 6-shogaol. These are structurally related to the capsaicin in chili peppers and activate similar receptors (TRPV1) in the nervous system.

Brown Fat Activation

Brown adipose tissue (BAT) is metabolically active fat found mainly in the upper back, neck, and chest. Unlike white fat, which stores energy, brown fat burns energy to produce heat through a process called thermogenesis — driven by a protein called UCP1. BAT activity declines with age and is suppressed in obesity, but it can be recruited and activated through cold exposure, certain foods, and compounds like those found in grains of paradise.

Grains of paradise extract and isolated 6-paradol trigger sympathetic nervous system signals that stimulate BAT thermogenesis [5]. Human studies using FDG-PET imaging have confirmed that oral ingestion of a standardized extract activates detectable BAT uptake in men with dormant or low BAT [1]. This means the spice can effectively "switch on" brown fat that might otherwise remain inactive.

Visceral Fat Reduction

Beyond thermogenesis, regular ingestion reduces visceral fat — the metabolically harmful fat stored around abdominal organs. In a four-week human trial, participants taking grains of paradise extract daily showed a significant decrease in visceral fat area compared to placebo, alongside increased resting energy expenditure [2]. A larger 12-week randomized controlled trial in 70 overweight adults found that 250 mg of standardized extract twice daily significantly reduced visceral fat accumulation and increased energy expenditure compared to placebo [4].

Anti-Inflammatory Effects

6-paradol inhibits cyclooxygenase-2 (COX-2), the enzyme central to the production of pro-inflammatory prostaglandins — the same target as ibuprofen and naproxen. In laboratory testing, the grains of paradise ethanolic extract reduced inflammation by 49% in a rodent edema model at 1000 mg/kg, and the isolated compounds showed dose-dependent COX-2 inhibition [3]. The extract also suppressed expression of multiple pro-inflammatory genes, suggesting effects beyond COX-2 alone.

Mood and Sleep Support

A 2025 randomized double-blind pilot trial found that grains of paradise extract at doses of 50–150 mg significantly reduced self-reported anxiety, tension, and stress, improved mood, and enhanced sleep quality within 48 hours of use [6]. The proposed mechanism involves inhibition of FAAH — the enzyme that breaks down anandamide, the body's natural "bliss" endocannabinoid — alongside modulation of serotonin (5-HT1A) and CB2 receptors.

Practical Use

Grains of paradise is available as a culinary spice (used in West African and North African cooking, and historically in medieval European cuisine) and as standardized extract supplements. Research doses have ranged from 30 mg to 500 mg of extract per day. As a spice, it can be used similarly to pepper. Look for extracts standardized to 6-paradol content for supplement use.

Cross-reference: See our brown fat and metabolism page for how cold exposure also activates brown adipose tissue.

Evidence Review

Brown Adipose Tissue Activation (Sugita et al., 2014)

Sugita and colleagues conducted a crossover study in 19 healthy men using FDG-PET/CT imaging after cold exposure. They identified 12 subjects with BAT-positive scans and found that oral ingestion of a grains of paradise extract (40 mg) significantly increased whole-body energy expenditure (+89 kcal/day on average) in those with BAT-positive status, compared to placebo. BAT-negative subjects showed no thermogenic response, confirming that the mechanism requires functional brown fat. The extract elevated metabolic rate within 30 minutes of ingestion. This was the first controlled human study to demonstrate BAT-mediated thermogenesis from an oral botanical supplement [1].

Visceral Fat Reduction — Daily Ingestion Trial (Sugita et al., 2014)

A separate trial by the same research group followed 19 subjects over four weeks with daily grains of paradise extract. The intervention group showed a significant reduction in visceral fat area (measured by CT scan) compared to placebo, with a concurrent increase in resting energy expenditure. No significant changes in subcutaneous fat, body weight, or BMI were observed over the short study period, suggesting the effect is specific to the more metabolically active visceral depot. The visceral-selective response is consistent with how BAT activation preferentially mobilizes visceral rather than subcutaneous fat [2].

Randomized Controlled Trial — Overweight Adults (Sudeep et al., 2022)

The most rigorous human trial enrolled 70 overweight adults (BMI 25–30) in a 12-week double-blind, placebo-controlled study. Participants received 250 mg of a standardized A. melegueta extract (AfperFit, standardized to 6-paradol) or placebo twice daily. The treatment group showed statistically significant reductions in visceral fat and improvements in resting energy expenditure compared to placebo. No serious adverse events were reported. Sample size (n=70) and study duration (12 weeks) represent a meaningful advancement over the earlier pilot work, though longer-term trials and studies in diverse populations are still needed [4].

Anti-Inflammatory Mechanisms (Ilic et al., 2014)

Ilic and colleagues conducted bioactivity-guided fractionation of grains of paradise ethanolic extract to identify the compounds responsible for COX-2 inhibition. 6-Paradol emerged as the primary COX-2 inhibitor, while 6-shogaol showed the greatest potency against pro-inflammatory gene expression. In a rat paw edema model (carrageenan-induced), the whole extract reduced inflammation by 49% at 1000 mg/kg, while individual isolates at 150 mg/kg produced 20–38% reductions depending on the compound. The study also demonstrated significant suppression of iNOS and IL-1β gene expression, indicating a multi-pathway anti-inflammatory mechanism that goes beyond COX inhibition alone [3].

Brown Fat Thermogenesis in Rodents (Iwami et al., 2011)

The preclinical mechanistic work by Iwami and colleagues established that both the whole extract and isolated 6-paradol activate BAT thermogenesis in rats by stimulating sympathetic nerve activity through TRPV1 receptor activation. This study provided the mechanistic rationale for subsequent human trials and confirmed the dose-response relationship between 6-paradol concentration and thermogenic output [5].

Anxiety, Mood, and Sleep (Pérez-Machín et al., 2025)

This randomized double-blind pilot trial in adults with moderate anxiety found that grains of paradise extract at 50–150 mg produced significant improvements in anxiety, tension, overall mood, and sleep quality within 48 hours compared to placebo, with no adverse effects reported. In vitro pharmacological testing identified FAAH inhibition as a key mechanism — by slowing the breakdown of anandamide, the extract may prolong the effects of the body's own endocannabinoid signaling. Modulation of 5-HT1A (serotonin) and CB2 receptors was also observed. These findings are preliminary and require larger trials, but suggest grains of paradise may have broader effects on the stress-anxiety axis beyond its thermogenic properties [6].

Overall Evidence Assessment

The thermogenic and visceral fat effects are supported by multiple human studies including one properly powered RCT, and the mechanism (BAT activation via sympathetic nervous system) is well-characterized. Anti-inflammatory activity is well-documented in vitro and in animal models. The anxiety/sleep findings are promising but based on a single pilot study. As a culinary spice with a long history of food use, the safety profile is favorable; supplement doses used in research are generally well-tolerated.

References

Grains of paradise (Aframomum melegueta) extract activates brown adipose tissue and increases whole-body energy expenditure in menSugita J, Yoneshiro T, Hatano T, Aita S, Ikemoto T, Uchiwa H, Iwanaga T, Kameya T, Kawai Y, Saito M. British Journal of Nutrition, 2014. PubMed 23308394 →
Daily ingestion of grains of paradise (Aframomum melegueta) extract increases whole-body energy expenditure and decreases visceral fat in humansSugita J, Yoneshiro T, Sugishima Y, Ikemoto T, Uchiwa H, Suzuki I, Saito M. Journal of Nutritional Science and Vitaminology, 2014. PubMed 24759256 →
Anti-inflammatory activity of grains of paradise (Aframomum melegueta Schum) extractIlic NM, Dey M, Poulev AA, Logendra S, Kuhn PE, Raskin I. Journal of Agricultural and Food Chemistry, 2014. PubMed 25293633 →
Aframomum melegueta Seed Extract with Standardized Content of 6-Paradol Reduces Visceral Fat and Enhances Energy Expenditure in Overweight Adults: A Randomized Double-Blind, Placebo-Controlled Clinical StudySudeep HV, Aman K, Jestin TV, Shyamprasad K. Drug Design, Development and Therapy, 2022. PubMed 36329722 →
Extract of grains of paradise and its active principle 6-paradol trigger thermogenesis of brown adipose tissue in ratsIwami M, Mahmoud FA, Shiina T, Hirayama H, Shima T, Sugita J, Shimizu Y. Autonomic Neuroscience, 2011. PubMed 21185236 →
Aframomum melegueta Seed Extract's Effects on Anxiety, Stress, Mood, and Sleep: A Randomized, Double-Blind, Pilot Clinical TrialPérez-Machín R, Vega-Morales T, Elvira-Aranda C, Lledó-Rico L, Gomis-Gomis MJ, López-Ríos L. Pharmaceuticals, 2025. PubMed 40006090 →